Several signaling pathways are aberrantly activated in T-ALL due to genetic alterations of their components and in response to external microenvironmental cues. To functionally characterize elements of the signaling network in T-ALL, here we analyzed ten signaling proteins that are frequently altered in T-ALL -namely Akt, Erk1/2, JNK, Lck, NF-κB p65, p38, STAT3, STAT5, ZAP70, Rb- in Jurkat, CEM and MOLT4 cell lines, using phospho-specific flow cytometry. Phosphorylation statuses of signaling proteins were measured in the basal condition or under modulation with H2O2, PMA, CXCL12 or IL7. Signaling profiles are characterized by a high variability across the analyzed T-ALL cell lines. Hierarchical clustering analysis documents that higher intr...
Chronic lymphocytic leukemia (CLL) patients exhibit a variable clinical course that reflects biologi...
B-cell chronic lymphocytic leukemia (B-CLL) patients exhibit a variable clinical course. Several bio...
Still about 20% of patients with acute lymphoblastic leukemia (ALL) struggle with relapse, despite i...
Several signaling pathways are aberrantly activated in T-ALL due to genetic alterations of their com...
The molecular events occurring during T-cell acute lymphoblastic leukemia (T-ALL) pathogenesis deter...
T-cell acute lymphoblastic leukemia (T-ALL) is a disease of the blood affecting T-lymphocytes. Altho...
AbstractAltered growth factor responses in phospho-protein-driven signaling networks are crucial to ...
T-cell lymphoblastic lymphoma (T-LBL) and lymphoblastic leukemia (T-ALL) arise from the transformati...
Protein kinase inhibitors are amongst the most successful cancer treatments, but targetable kinases ...
: T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive cancer arising from lymphoblasts of T...
Chronic lymphocytic leukemia (CLL) has a high incidence and a steeply growing prevalence in the West...
Background Knowledge about signaling pathways in malignant cells may provide prognos...
Still about 20% of patients with acute lymphoblastic leukemia (ALL) struggle with relapse, despite i...
B-cell acute lymphoblastic leukemia (B-ALL) represents a collection of diseases that are categorized...
B-cell chronic lymphocytic leukemia (B-CLL) is a clonal lymphoproliferative disease characterized by...
Chronic lymphocytic leukemia (CLL) patients exhibit a variable clinical course that reflects biologi...
B-cell chronic lymphocytic leukemia (B-CLL) patients exhibit a variable clinical course. Several bio...
Still about 20% of patients with acute lymphoblastic leukemia (ALL) struggle with relapse, despite i...
Several signaling pathways are aberrantly activated in T-ALL due to genetic alterations of their com...
The molecular events occurring during T-cell acute lymphoblastic leukemia (T-ALL) pathogenesis deter...
T-cell acute lymphoblastic leukemia (T-ALL) is a disease of the blood affecting T-lymphocytes. Altho...
AbstractAltered growth factor responses in phospho-protein-driven signaling networks are crucial to ...
T-cell lymphoblastic lymphoma (T-LBL) and lymphoblastic leukemia (T-ALL) arise from the transformati...
Protein kinase inhibitors are amongst the most successful cancer treatments, but targetable kinases ...
: T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive cancer arising from lymphoblasts of T...
Chronic lymphocytic leukemia (CLL) has a high incidence and a steeply growing prevalence in the West...
Background Knowledge about signaling pathways in malignant cells may provide prognos...
Still about 20% of patients with acute lymphoblastic leukemia (ALL) struggle with relapse, despite i...
B-cell acute lymphoblastic leukemia (B-ALL) represents a collection of diseases that are categorized...
B-cell chronic lymphocytic leukemia (B-CLL) is a clonal lymphoproliferative disease characterized by...
Chronic lymphocytic leukemia (CLL) patients exhibit a variable clinical course that reflects biologi...
B-cell chronic lymphocytic leukemia (B-CLL) patients exhibit a variable clinical course. Several bio...
Still about 20% of patients with acute lymphoblastic leukemia (ALL) struggle with relapse, despite i...